| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 08/28/2013 | EP2629773A2 Chemosensory receptor ligand-based therapies |
| 08/28/2013 | EP2629610A1 Methods and compositions for preventing and relieving muscle cramps and for recovery from neuromuscular irritability and fatigue following exercise |
| 08/28/2013 | CN103269695A Methods for facilitating muscle recovery after a period of disuse using beta-ydroxy-beta-<wbr/>methylbutyrate |
| 08/28/2013 | CN103263598A Chinese medicine preparation for treating peripheral facial paralysis diseases |
| 08/28/2013 | CN103263504A Compound essential oil capable of effectively preventing leg cramp |
| 08/28/2013 | CN103263439A CD34 stem cell-related methods and compositions |
| 08/28/2013 | CN102026974B Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 08/28/2013 | CN101970458B Novel gamma-secretase inhibitor |
| 08/28/2013 | CN101522707B 肌肉生长抑制素拮抗剂 Myostatin antagonists |
| 08/27/2013 | US8518999 Modulators of TNF-αsignaling |
| 08/27/2013 | US8518967 Amides of acetic and propionic acids |
| 08/27/2013 | US8518411 Modified TGF-β superfamily protein |
| 08/21/2013 | CN203139401U Waist protection physiotherapy enclosing tool |
| 08/21/2013 | CN1533374B Substitutled cyclohexane-1,4-diamine derivatives |
| 08/21/2013 | CN103254205A Spirocyclic derivatives as histone deacetylase inhibitors |
| 08/21/2013 | CN103254190A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 08/21/2013 | CN103254177A Modulators of atp-binding cassette transporters |
| 08/21/2013 | CN103251953A Flt3 inhibitors for immune suppression |
| 08/21/2013 | CN103251732A Intramuscular injection nodule plaster |
| 08/21/2013 | CN102697929B Hydrophilic Chinese medicinal patch and preparation method thereof |
| 08/21/2013 | CN102106884B Medicinal composition having immunity-regulating function |
| 08/20/2013 | US8512767 Pharmaceutical compositions |
| 08/20/2013 | CA2669800C Nerve elongation promoter and elongation inhibitor |
| 08/15/2013 | US20130210869 Method of increasing the extent of absorption of tizanidine |
| 08/15/2013 | US20130210136 Methods For Treating Cardio Pulmonary Diseases With NO Group Compounds |
| 08/14/2013 | CN102397272B Application of butylphthalide and derivatives thereof in preparation of medicines for preventing and treating ALS |
| 08/14/2013 | CN102309461B Pyridostigmine bromide odor masking dispersible tablets and preparation method thereof |
| 08/14/2013 | CN102284016B Body resistance-strengthening and evil-eliminating internal and external therapy traditional Chinese medicine for treating rheumatism of muscles and bones |
| 08/14/2013 | CN102258575B Plaster for treating scapulohumeral periarthritis and its preparation method |
| 08/14/2013 | CN101838260B Dihydropyrrolones derivative as Caspase-3 inhibitor |
| 08/13/2013 | US8507748 Method for the production of a single heavy chain antibody |
| 08/13/2013 | CA2768841C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2768828C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2768773C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2543406C Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 08/08/2013 | WO2013116691A1 Methods for improving muscle strength |
| 08/08/2013 | WO2013114413A1 Diethyl- [6- (4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl) - naphthalen-2-yl-methyl] -ammonium chloride for use in the treatment of muscular dystrophy |
| 08/08/2013 | WO2013113857A1 (1r,4r)-6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro-[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for treating fibromyalgia and chronic fatigue syndrome |
| 08/08/2013 | US20130203811 Thalidomide and thalidomide analogues for the prevention and treatment of sarcopenia |
| 08/08/2013 | CA2857082A1 Diethyl-[6- (4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)- naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dysttrophy |
| 08/07/2013 | CN103232521A Tanshinone imidazole compound and its preparation method and use |
| 08/07/2013 | CN103232454A Medicine for treating mental disease |
| 08/07/2013 | CN103230595A Composition for treating mental diseases |
| 08/07/2013 | CN103230592A Composition of statin medicine and 5-methyltetrahydrofolic acid, and application thereof |
| 08/07/2013 | CN103230547A Traditional Chinese medicine for treating intractable hiccup |
| 08/07/2013 | CN103230540A Plaster for treating facial paralysis and preparation method thereof |
| 08/07/2013 | CN103230520A Preparation method of traditional Chinese medicine lotion for treating trauma-type felon |
| 08/07/2013 | CN103230348A Yao drug bath lotion and preparation method thereof |
| 08/06/2013 | US8502014 Method for the production of a single heavy chain antibody |
| 08/06/2013 | US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/06/2013 | US8501240 Compositions comprising an active agent |
| 08/06/2013 | CA2477075C Pharmaceutical and cosmetic compositions comprising plgf-1 |
| 08/06/2013 | CA2368213C Specifically targeted catalytic antagonists and uses thereof |
| 08/01/2013 | WO2013112053A1 Rna modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy |
| 08/01/2013 | WO2013054866A8 Agent for preventing or treating htlv-i associated myelopathy |
| 08/01/2013 | US20130197014 Purinone compounds as kinase inhibitors |
| 08/01/2013 | US20130196987 Macrocyclic compounds useful as pharmaceuticals |
| 08/01/2013 | US20130196849 Substituted Cellulose Acetates and Uses Thereof |
| 08/01/2013 | US20130195834 Treatment of glycogen storage disease type ii |
| 07/31/2013 | EP2620155A1 Medicine containing Cimicifuga for use in the treatment of sarcopenia and myocardial weakness |
| 07/31/2013 | EP2620154A1 Drug against central nervous system inflammation |
| 07/31/2013 | EP2618666A1 Novel dihydropyrimidin-2(1h)-one compounds as neurokinin-3 receptor antagonists |
| 07/31/2013 | CN103223177A Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene |
| 07/31/2013 | CN103223081A Grass oil for treating arthritis and traumatic injury |
| 07/31/2013 | CN103223015A Muscle soreness and skin itch treatment drug composition and preparation method thereof |
| 07/31/2013 | CN102793882B Traditional Chinese medicine for treatment of myasthenia gravis |
| 07/30/2013 | CA2422774C Remedies for amyotrophic lateral sclerosis |
| 07/25/2013 | WO2013108926A1 Prophylactic and therapeutic drug for amyotrophic lateral sclerosis and method of screening therefor |
| 07/25/2013 | US20130190350 Mediators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto |
| 07/25/2013 | US20130189344 Human lubrication gel |
| 07/25/2013 | US20130189343 Transmucosal administration system for a pharmaceutical drug |
| 07/25/2013 | US20130189240 Composition containing pias3 as an active ingredient for preventing or treating cancer or immune disease |
| 07/24/2013 | EP2617737A1 High purity heparin and production method therefor |
| 07/24/2013 | EP2616085A2 Compositions and method for promoting musculoskeletal repair |
| 07/24/2013 | CN1822845B Means for preventing and treating cellular death and their biological applications |
| 07/24/2013 | CN103221426A Antibodies that bind myostatin, compositions and methods |
| 07/24/2013 | CN103214576A IL-17 receptor A antigen binding proteins |
| 07/24/2013 | CN103214555A Peptide inhibitors for mediating stress responses |
| 07/24/2013 | CN103214484A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 07/24/2013 | CN103214483A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 07/24/2013 | CN103214450A Modulators of atp-binding cassette transporters |
| 07/24/2013 | CN103214376A Substituted 4-aminocyclohexane derivatives |
| 07/24/2013 | CN103212085A Molecules for targeting compounds to various selected organs or tissues |
| 07/24/2013 | CN103211824A Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| 07/24/2013 | CN102256942B New polymorphic form of 1- (4- { l- [ (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino] -ethyl) -2-ethyl-benzyl) -azetidine-3-formic acid |
| 07/24/2013 | CN101863948B High-purity (2 beta, 3 alpha, 5 alpha, 16 beta, 17 beta)-2-(4-morpholinyl)-16-(1-pyrrolidinyl)-androstane-3,17-diol or composition thereof and preparation method thereof |
| 07/23/2013 | US8492416 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/23/2013 | CA2544574C Stable vitamin b6 derivative |
| 07/18/2013 | US20130184325 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf |
| 07/17/2013 | EP2614827A2 Means and methods for counteracting muscle disorders |
| 07/17/2013 | EP2614824A1 Therapeutic agent for pain |
| 07/17/2013 | EP2613776A2 Composition and method for muscle repair and regeneration |
| 07/17/2013 | CN103209997A High purity heparin and production method therefor |
| 07/17/2013 | CN103204794A New Salts |
| 07/17/2013 | CN103202976A Traditional Chinese medicine extract for treating myasthenia gravis and preparation method thereof |
| 07/17/2013 | CN103202845A Pharmaceutical Composition Of A Sodium Channel Blocker And A Selective Serotonin Uptake Inhibitor |
| 07/17/2013 | CN103202815A Injection for treating mental disease |
| 07/17/2013 | CN101928329B Tripeptide boric acid (ester) compound and preparation method and application thereof |
| 07/17/2013 | CN101379086B Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders |
| 07/16/2013 | US8486698 Inducing differentiation of an isolated marrow stromal cell into a neuronal cell tissue engineering for use in prevention and treatment of nervous system disorders; regenerative medicine; tissue engineering |